JPS648637B2 - - Google Patents
Info
- Publication number
- JPS648637B2 JPS648637B2 JP10812180A JP10812180A JPS648637B2 JP S648637 B2 JPS648637 B2 JP S648637B2 JP 10812180 A JP10812180 A JP 10812180A JP 10812180 A JP10812180 A JP 10812180A JP S648637 B2 JPS648637 B2 JP S648637B2
- Authority
- JP
- Japan
- Prior art keywords
- phosphate buffer
- around
- reaction
- anticancer substance
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008363 phosphate buffer Substances 0.000 claims description 36
- 230000001093 anti-cancer Effects 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 206010028980 Neoplasm Diseases 0.000 claims description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 21
- 239000011780 sodium chloride Substances 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000010521 absorption reaction Methods 0.000 claims description 16
- 150000002500 ions Chemical class 0.000 claims description 16
- 201000011510 cancer Diseases 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 14
- 241000605909 Fusobacterium Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 241000699670 Mus sp. Species 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 claims description 9
- 241000605986 Fusobacterium nucleatum Species 0.000 claims description 8
- 238000000862 absorption spectrum Methods 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 229920005654 Sephadex Polymers 0.000 claims description 7
- 239000012507 Sephadex⢠Substances 0.000 claims description 7
- 238000011481 absorbance measurement Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 201000009030 Carcinoma Diseases 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000011800 void material Substances 0.000 claims description 6
- 206010003445 Ascites Diseases 0.000 claims description 5
- 208000006268 Sarcoma 180 Diseases 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002246 antineoplastic agent Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 230000003308 immunostimulating effect Effects 0.000 claims description 4
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000000921 elemental analysis Methods 0.000 claims description 3
- 239000010200 folin Substances 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- RJTZUHVCZIGJMB-UHFFFAOYSA-N hydron;1h-indole;chloride Chemical compound Cl.C1=CC=C2NC=CC2=C1 RJTZUHVCZIGJMB-UHFFFAOYSA-N 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 3
- 230000035755 proliferation Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 24
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000002504 physiological saline solution Substances 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- -1 ethanol and methanol Chemical class 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 239000004158 L-cystine Substances 0.000 description 2
- 235000019393 L-cystine Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940066779 peptones Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002399 phagocytotic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 description 1
- 229940046307 sodium thioglycolate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
æ¬çºæã¯æ°èŠãªå¶çæ§ç©è³ªãæŽã«è©³çŽ°ã«ã¯ããœ
ãã¯ããªãŠã å±ã«å±ããèãå¹é€ãããã®å¹é€æ¶²
ããåŸãããå¶çæ§ç©è³ªTFâ133bã«é¢ãããæŽ
ã«ãŸããæ¬çºæã¯ãã®å¶çæ§ç©è³ªTFâ133bã補
é ããæ¹æ³äžŠã³ã«ãããå«æããå¶çå€ã«é¢ã
ãã è¿å¹Žãåçš®ã®çæ£è ã®æ²»çæ³ã«ãããŠã宿䞻ã®
å ç«æ©èœã亢é²ãããå ç«æ©èœã®å©ããåããªã
ãå¶çå¹æãçºçŸãããæ²»çæ³ãçããšãªã€ãŠæ¥
ããæ¯ãçæ³ã«äœ¿çšãããè¬å€ãšããŠã¯ãå皮现
èã®èäœãèäœå¹é€ç©ããåŸãããæåãããã
ã¯æ åèã®åå®äœåã¯ãã®å¹é€èäœããåŸããã
å€ç³äœãç¥ãããŠããããããããããã®è¬å€ã¯
å¹æãå¯äœçšåã³ãã®è£œé æ³çã®ç¹ã§æªã æºè¶³ã
åŸããã®ã§ã¯ãªãã äžæ¹ãŸããããœãã¯ããªãŠã å±ã«å±ããèãäŸ
ãã°ããœãã¯ããªãŠã ã»K031â3Bãããœãã¯ã
ãªãŠã ã»ãã·ããªãã¹ïŒ·â12ãããœãã¯ããªãŠ
ã ã»ã®ã©ã³ã¹1012åã³ããœãã¯ããªãŠã ã»ãã¯ã¬
ã¢ã¿ã 1010ãå¹é€ããŠåŸãèäœåã³äžæž 液ã«é¢ã
ãå ±åãã¿ãããããå£ç§èª21ïŒ534é ã539é
ïŒ1972ïŒãå£ç§èª23ïŒ322ã333é ïŒ1974ïŒãããã
ãªãããããœãã¯ããªãŠã å±ã«å±ããèãå¹é€ã
ãŠåŸãããå¹é€æ¶²åã¯äžæž 液ããåŸãããæå䞊
ã³ã«ãã®è¬çäœçšã«ã€ããŠã¯æªã ç 究ãããŠããª
ãã ããã§ãæ¬çºæè ã¯ããœãã¯ããªãŠã å±ã«å±ã
ãèãå¹é€ãããã®å¹é€æ¶²ããèäœãé€å»ããäž
æž æ¶²ã«ã€ããŠããã®è¬çäœçšã調ã¹ãŠãããšã
ãããã®äžæž 液ããæ¡åãããç¹å®ã®æåã匷ã
å¶çäœçšãæããããšããããããã¯ãã³ãããŒ
圢ææå¶æ³ã«ãããŠã¯ç现èã®éèœåœ¢æé»æ¢äœçš
ã¯æ¥µããŠå°ããã殺现èã«ããå¶çäœçšã§ã¯ãª
ãã宿䞻ä»åšæ§ãããã¯å®¿äž»ã®å ç«åã亢é²ã
ããå ç«åã®å©ããåããªããéæ¥çã«å¶çäœçš
ãçºçŸãããäœçšãæãããã®ã§ããããšãæŽã«
ãã®æåã¯æ¯æ§ã極ããŠäœãããšãèŠåºããæ¬çº
æãå®æããã æ¬çºæã§å©çšãããèãšããŠã¯ãããœãã¯ããª
ãŠã å±ã«å±ããTFâ133bçç£èã§ããã°ããã
ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã ã奜é©ã«æãã
ãããäŸãã°ãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã
TFâ031ïŒFARMâ5077ïŒATCCâ31647ïŒçã®
èæ ªãå©çšãããã ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TFâ031ã®è
åŠçæ§ç¶ãèšèŒããã°äžèšã®åŠãã§ããã (1) 圢æ 现èã®åœ¢ïŒçŽ¡é圢ïŒç¬¬ïŒå³ïŒ 现èã®å€åœ¢æ§ã®æç¡ïŒãªã éåæ§ã®æç¡ïŒãªã èåã®æç¡ïŒãªã ã°ã©ã æè²ïŒã°ã©ã é°æ§ æé žæ§ïŒé°æ§ (2) å¹å°ã«ãããçè²ç¶æ TFâïœå¯å€©å¹³æ¿åã³æé¢å¹å° å€ åœ¢ïŒå圢 倧ããïŒçŽïŒmm é èµ·ïŒåçç¶ æ§ é ïŒé²æ»Žç¶ è¡š é¢ïŒå¹³ æ» èŸº çžïŒå¹³ æ» è² ïŒä¹³é»çœè² éæ床ïŒäžéæ TFâïœæ¶²äœå¹å° çºè²ã®çšåºŠïŒæºç æ¿ ãïŒå å¡ æ² æŸ±ïŒãª ã è¡šé¢ã®çºè²ïŒãªããçŽïŒmmãŸã§ã¯çºè²ãªã 㬠ã¹ïŒãª ã (3) ççåŠçæ§è³ª ç¡«åæ°ŽçŽ ã®çæïŒïŒ ç¡é žå¡©ã®éå ïŒâ é ªé žã®çæïŒïŒ ã€ã³ããŒã«ã®çæïŒïŒ ãŠã¬ã¢ãŒãŒïŒâ ã«ã¿ã©ãŒãŒïŒâ ãã³ãã³ã®å æ°Žå解ïŒâ é žçŽ ã«å¯Ÿããæ 床ïŒå«æ°æ§ ã¢ã³ã¢ãã¢ã®çæïŒïŒ çé žã¬ã¹ã®çæïŒïŒ çè²ã®ç¯å²ïŒPHïŒã8.5 枩床30ã45â ç³ããã®ã¬ã¹ã®çæ âã¢ã©ãããŒã¹ïŒâïŒãâãã·ããŒã¹
ïŒâïŒãâã°ã«ã³ãŒã¹ïŒâïŒãâãã³ã
ãŒã¹ïŒâïŒãâãã©ã¯ããŒã¹ïŒâïŒãâ
ã¬ã©ã¯ããŒã¹ïŒâïŒã麊èœç³ïŒâïŒãã·ãšç³
ïŒâïŒããã¬ãããŒã¹ïŒâïŒããœã«ããã
ïŒâïŒããã³ãããŒã«ïŒâïŒãã€ãã·ãã
ïŒâïŒãã°ãªã»ãªã³ïŒâïŒããã³ãã³ïŒâïŒ ä»¥äžã®è«žæ§ç¶ãããŒãžãŒãºã»ãããŠã¢ã«ã»ãª
ãã»ãã€ã¿ããã€ãã€ãã»ãã¯ããªãªããžãŒç¬¬ïŒ
çã«ç §ããŠæ€èšãããšãæ¬èæ ªã¯ããœãã¯ããªãŠ
ã ã»ãã¯ã¬ã¢ã¿ã ïŒFusobacterium nucleatumïŒ
ã«é ·äŒŒããããã«å±ããã ã€ãã«ãæ¬çºæã®å¶çæ§ç©è³ªTFâ133bã®è£œé
æ³ãå³åŒåããŠèª¬æããã°ã次ã®ãšããã§ããã
ãã¯ããªãŠã å±ã«å±ããèãå¹é€ãããã®å¹é€æ¶²
ããåŸãããå¶çæ§ç©è³ªTFâ133bã«é¢ãããæŽ
ã«ãŸããæ¬çºæã¯ãã®å¶çæ§ç©è³ªTFâ133bã補
é ããæ¹æ³äžŠã³ã«ãããå«æããå¶çå€ã«é¢ã
ãã è¿å¹Žãåçš®ã®çæ£è ã®æ²»çæ³ã«ãããŠã宿䞻ã®
å ç«æ©èœã亢é²ãããå ç«æ©èœã®å©ããåããªã
ãå¶çå¹æãçºçŸãããæ²»çæ³ãçããšãªã€ãŠæ¥
ããæ¯ãçæ³ã«äœ¿çšãããè¬å€ãšããŠã¯ãå皮现
èã®èäœãèäœå¹é€ç©ããåŸãããæåãããã
ã¯æ åèã®åå®äœåã¯ãã®å¹é€èäœããåŸããã
å€ç³äœãç¥ãããŠããããããããããã®è¬å€ã¯
å¹æãå¯äœçšåã³ãã®è£œé æ³çã®ç¹ã§æªã æºè¶³ã
åŸããã®ã§ã¯ãªãã äžæ¹ãŸããããœãã¯ããªãŠã å±ã«å±ããèãäŸ
ãã°ããœãã¯ããªãŠã ã»K031â3Bãããœãã¯ã
ãªãŠã ã»ãã·ããªãã¹ïŒ·â12ãããœãã¯ããªãŠ
ã ã»ã®ã©ã³ã¹1012åã³ããœãã¯ããªãŠã ã»ãã¯ã¬
ã¢ã¿ã 1010ãå¹é€ããŠåŸãèäœåã³äžæž 液ã«é¢ã
ãå ±åãã¿ãããããå£ç§èª21ïŒ534é ã539é
ïŒ1972ïŒãå£ç§èª23ïŒ322ã333é ïŒ1974ïŒãããã
ãªãããããœãã¯ããªãŠã å±ã«å±ããèãå¹é€ã
ãŠåŸãããå¹é€æ¶²åã¯äžæž 液ããåŸãããæå䞊
ã³ã«ãã®è¬çäœçšã«ã€ããŠã¯æªã ç 究ãããŠããª
ãã ããã§ãæ¬çºæè ã¯ããœãã¯ããªãŠã å±ã«å±ã
ãèãå¹é€ãããã®å¹é€æ¶²ããèäœãé€å»ããäž
æž æ¶²ã«ã€ããŠããã®è¬çäœçšã調ã¹ãŠãããšã
ãããã®äžæž 液ããæ¡åãããç¹å®ã®æåã匷ã
å¶çäœçšãæããããšããããããã¯ãã³ãããŒ
圢ææå¶æ³ã«ãããŠã¯ç现èã®éèœåœ¢æé»æ¢äœçš
ã¯æ¥µããŠå°ããã殺现èã«ããå¶çäœçšã§ã¯ãª
ãã宿䞻ä»åšæ§ãããã¯å®¿äž»ã®å ç«åã亢é²ã
ããå ç«åã®å©ããåããªããéæ¥çã«å¶çäœçš
ãçºçŸãããäœçšãæãããã®ã§ããããšãæŽã«
ãã®æåã¯æ¯æ§ã極ããŠäœãããšãèŠåºããæ¬çº
æãå®æããã æ¬çºæã§å©çšãããèãšããŠã¯ãããœãã¯ããª
ãŠã å±ã«å±ããTFâ133bçç£èã§ããã°ããã
ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã ã奜é©ã«æãã
ãããäŸãã°ãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã
TFâ031ïŒFARMâ5077ïŒATCCâ31647ïŒçã®
èæ ªãå©çšãããã ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TFâ031ã®è
åŠçæ§ç¶ãèšèŒããã°äžèšã®åŠãã§ããã (1) 圢æ 现èã®åœ¢ïŒçŽ¡é圢ïŒç¬¬ïŒå³ïŒ 现èã®å€åœ¢æ§ã®æç¡ïŒãªã éåæ§ã®æç¡ïŒãªã èåã®æç¡ïŒãªã ã°ã©ã æè²ïŒã°ã©ã é°æ§ æé žæ§ïŒé°æ§ (2) å¹å°ã«ãããçè²ç¶æ TFâïœå¯å€©å¹³æ¿åã³æé¢å¹å° å€ åœ¢ïŒå圢 倧ããïŒçŽïŒmm é èµ·ïŒåçç¶ æ§ é ïŒé²æ»Žç¶ è¡š é¢ïŒå¹³ æ» èŸº çžïŒå¹³ æ» è² ïŒä¹³é»çœè² éæ床ïŒäžéæ TFâïœæ¶²äœå¹å° çºè²ã®çšåºŠïŒæºç æ¿ ãïŒå å¡ æ² æŸ±ïŒãª ã è¡šé¢ã®çºè²ïŒãªããçŽïŒmmãŸã§ã¯çºè²ãªã 㬠ã¹ïŒãª ã (3) ççåŠçæ§è³ª ç¡«åæ°ŽçŽ ã®çæïŒïŒ ç¡é žå¡©ã®éå ïŒâ é ªé žã®çæïŒïŒ ã€ã³ããŒã«ã®çæïŒïŒ ãŠã¬ã¢ãŒãŒïŒâ ã«ã¿ã©ãŒãŒïŒâ ãã³ãã³ã®å æ°Žå解ïŒâ é žçŽ ã«å¯Ÿããæ 床ïŒå«æ°æ§ ã¢ã³ã¢ãã¢ã®çæïŒïŒ çé žã¬ã¹ã®çæïŒïŒ çè²ã®ç¯å²ïŒPHïŒã8.5 枩床30ã45â ç³ããã®ã¬ã¹ã®çæ âã¢ã©ãããŒã¹ïŒâïŒãâãã·ããŒã¹
ïŒâïŒãâã°ã«ã³ãŒã¹ïŒâïŒãâãã³ã
ãŒã¹ïŒâïŒãâãã©ã¯ããŒã¹ïŒâïŒãâ
ã¬ã©ã¯ããŒã¹ïŒâïŒã麊èœç³ïŒâïŒãã·ãšç³
ïŒâïŒããã¬ãããŒã¹ïŒâïŒããœã«ããã
ïŒâïŒããã³ãããŒã«ïŒâïŒãã€ãã·ãã
ïŒâïŒãã°ãªã»ãªã³ïŒâïŒããã³ãã³ïŒâïŒ ä»¥äžã®è«žæ§ç¶ãããŒãžãŒãºã»ãããŠã¢ã«ã»ãª
ãã»ãã€ã¿ããã€ãã€ãã»ãã¯ããªãªããžãŒç¬¬ïŒ
çã«ç §ããŠæ€èšãããšãæ¬èæ ªã¯ããœãã¯ããªãŠ
ã ã»ãã¯ã¬ã¢ã¿ã ïŒFusobacterium nucleatumïŒ
ã«é ·äŒŒããããã«å±ããã ã€ãã«ãæ¬çºæã®å¶çæ§ç©è³ªTFâ133bã®è£œé
æ³ãå³åŒåããŠèª¬æããã°ã次ã®ãšããã§ããã
ãè¡šã
ãè¡šã
äžèšã®è£œé æ³ãå
·äœçã«ç€ºããšæ¬¡ã®éãã§ã
ãã (a) å¹é€ ããœãã¯ããªãŠã å±ã«å±ããèã®å¹é€ã¯ãéåžž
ã®å«æ°æ§èã®å¹é€ã«ãã€ãŠè¡ãªããããå³ã¡ãç
ã®è³ãå¿èæœåºç©ãåçš®ãããã³é¡çã®çªçŽ æºïŒ
ã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯ãçã®ãã¿ãã³æºïŒå¡©å
ãããªãŠã çã®ç¡æ©å¡©é¡ïŒã°ã«ã³ãŒã¹ãã©ã¯ããŒ
ã¹çã®ççŽ æºïŒïŒ¬âã·ã¹ãã³ãäºç¡«é žãããªãŠ
ã ãããªã°ãªã³ã¬ãŒãçã®éå å€ãå«ããããªå¹
å°ãæ°Žé žåãããªãŠã ã§PHïŒã8.5奜ãŸããã¯7.2
ã8.2ã«èª¿æŽããèãæ€ãã€ããå«æ°çæ¡ä»¶äžã
35ã42â奜ãŸããã¯36ã38âã§ïŒãïŒæ¥ã奜ãŸã
ãã¯24ã72æéé眮å¹é€ãè¡ãªããç¹ã«ãäžèšæ
åè¡šã«èšèŒã®å¹å°ïŒä»¥äžTFå¹å°ãšç§°ããïŒã䜿
çšããã®ã奜ãŸãããããããççŽ æºãšããŠãç
ã®è³ãå¿èæœåºç©ã®ãã¬ã€ã³ã»ããŒãã»ã€ã³ããŠ
ãŒãžãšã³ã¯å¿ ãããå¿ èŠã§ã¯ãªããçã®å¿èæœåº
ç©ã§ããããŒãã»ã€ã³ããŠãŒãžãšã³ãçèãšã
ã¹ãéèãšãã¹ãããŠã¢ãã³ã·ããæœåºãããã³
ãŒã³ã¹ãã€ããªã«çã代çšããŠããããåãåçš®
ãããã³ã«æŒããŠããããªãŒã¹ã»ãããã³ããã¢
ã€ãã³ã»ãããã³ã¯å¿ ãããå¿ èŠã§ã¯ãªããããª
ããã±ãŒã¹ã»ãããã³ã¯ããªãããã³ã«ãŠä»£çšã
ãããšãã§ããã å°ãå¯å€©ã䜿çšããªããšãã¯æ¹æå¹é€ãè¡ãªã
ã®ã奜ãŸããã
ãã (a) å¹é€ ããœãã¯ããªãŠã å±ã«å±ããèã®å¹é€ã¯ãéåžž
ã®å«æ°æ§èã®å¹é€ã«ãã€ãŠè¡ãªããããå³ã¡ãç
ã®è³ãå¿èæœåºç©ãåçš®ãããã³é¡çã®çªçŽ æºïŒ
ã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯ãçã®ãã¿ãã³æºïŒå¡©å
ãããªãŠã çã®ç¡æ©å¡©é¡ïŒã°ã«ã³ãŒã¹ãã©ã¯ããŒ
ã¹çã®ççŽ æºïŒïŒ¬âã·ã¹ãã³ãäºç¡«é žãããªãŠ
ã ãããªã°ãªã³ã¬ãŒãçã®éå å€ãå«ããããªå¹
å°ãæ°Žé žåãããªãŠã ã§PHïŒã8.5奜ãŸããã¯7.2
ã8.2ã«èª¿æŽããèãæ€ãã€ããå«æ°çæ¡ä»¶äžã
35ã42â奜ãŸããã¯36ã38âã§ïŒãïŒæ¥ã奜ãŸã
ãã¯24ã72æéé眮å¹é€ãè¡ãªããç¹ã«ãäžèšæ
åè¡šã«èšèŒã®å¹å°ïŒä»¥äžTFå¹å°ãšç§°ããïŒã䜿
çšããã®ã奜ãŸãããããããççŽ æºãšããŠãç
ã®è³ãå¿èæœåºç©ã®ãã¬ã€ã³ã»ããŒãã»ã€ã³ããŠ
ãŒãžãšã³ã¯å¿ ãããå¿ èŠã§ã¯ãªããçã®å¿èæœåº
ç©ã§ããããŒãã»ã€ã³ããŠãŒãžãšã³ãçèãšã
ã¹ãéèãšãã¹ãããŠã¢ãã³ã·ããæœåºãããã³
ãŒã³ã¹ãã€ããªã«çã代çšããŠããããåãåçš®
ãããã³ã«æŒããŠããããªãŒã¹ã»ãããã³ããã¢
ã€ãã³ã»ãããã³ã¯å¿ ãããå¿ èŠã§ã¯ãªããããª
ããã±ãŒã¹ã»ãããã³ã¯ããªãããã³ã«ãŠä»£çšã
ãããšãã§ããã å°ãå¯å€©ã䜿çšããªããšãã¯æ¹æå¹é€ãè¡ãªã
ã®ã奜ãŸããã
ãè¡šã
(b) å¹é€æ¶²ããäžæž
液ã®æ¡åïŒèäœã®é€å»ïŒ
äžã§åŸãå¹é€æ¶²ããèäœãé€å»ããŠäžæž
液ãåŸ
ããèäœã®é€å»ã¯åžžæ³ãäŸãã°é å¿åé¢ããã€ã
ãã¹ãŒããŒã»ã«çã®éå©å€ãçšããéæ³ãæ¡
çšã§ããããç¹ã«é å¿åé¢æ³ã¯æäœãèã®é€å»åºŠ
åãäžæž 液ã®ååŸéã®ç¹ã§å¥œãŸãããåãèäœã®
é€å»ã¯ãã®æ®µéã§è¡ãªãã®ã奜ãŸããã次ã®(c)ã®
æäœã«ãããŠé€å»ããŠãããã (c) å¶çæ§ç©è³ªTFâ133bã®æ¡å äžã§åŸãããäžæž 液åã¯å¹é€æ¶²ã«èŠªæ°Žæ§ææ©æº¶
åªãå ããŠãçããæ²æŸ±ç©ãæ¡åããããã®éã®
äžæž 液åã¯å¹é€æ¶²ã¯PHïŒãïŒã«èª¿æŽããã®ã奜ãŸ
ããã芪氎æ§ææ©æº¶åªãšããŠã¯ãäŸãã°ãšã¿ããŒ
ã«ãã¡ã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡ãã¢ã»ãã³çã®
ã±ãã³é¡ãæããããããã¢ã«ã³ãŒã«é¡ç¹ã«ãšã¿
ããŒã«ãæãããçµæãäžããããã®èŠªæ°Žæ§ææ©
溶åªã¯ãã®æ¿åºŠã30ã70ïŒ ã奜ãŸããã¯50ã70ïŒ
ã«ãªãããã«æ·»å ããã®ã奜é©ã§ããã芪氎æ§æ
æ©æº¶åªãå ããåŸãäœæž©ã奜ãŸããã¯çŽïŒâã®æž©
床ã§æ°æéãæ°æ¥éæŸåž¯çœ®ããæ²æŸ±ç©ã®çæãå®
çµãããã ãã®ããã«ããŠçããæ²æŸ±ç©ããã«ã³ããŒã·ãš
ã³ãé å¿åé¢ãéçã®éåžžã®æäœã§åé¢ããã 次ãã§ããã®æ²æŸ±ç©ã«10ã15åéã®æ°Žåã¯ãªã³
é žç·©è¡æ¶²ïŒé£å¡©ïŒãå ããçããæ°Žäžæº¶ç©ãé å¿
åé¢ãéçã®éåžžã®æ¹æ³ã§é€å»ãããå¹é€æ¶²ã
䜿çšãããšãã¯ãã®åŠçã«ããèäœãé€å»ãã
ããæŽã«æ¯ãããŠåŸãããæ°Žå¯æº¶æåã®åé¢æ¶²ã
ãã®ãŸãŸã€ãªã³äº€æäœåŠçã«ä»ããããšãã§ãã
ãããã®æ°Žå¯æº¶æåãéæåã¯éå€éãããã®
å 液ãåã¯ãæŽã«åçµä¹Ÿç¥çã«ãã€ãŠä¹Ÿç¥ããŠç²
æ«ãã€ãªã³äº€æäœåŠçã«ä»ããŠãããã æ¯ãããŠåŸãããäžèšæ°Žå¯æº¶æååã¯éæåã¯
éå€éããå 液æåã«ã€ããŠã€ãªäº€æäœåŠçã
ããã€ãªã³äº€æäœãšããŠã¯ã匱塩åºæ§ã€ãªã³äº€æ
äœåã¯åå篩æ§ã䜵æãããã®ã䜿çšããã®ã奜
ãŸãããäŸãã°ãžãšãã«ã¢ãããšãã«âã»ãã¢ã
ãã¯ã¹ïŒ¡â50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒã奜é©
ã«äœ¿çšããããã€ãªã³äº€æäœåŠçã«ãããŠãå¶ç
æ§ç©è³ªTFâ133bã¯ã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²
ïŒãã®æ现æžã§âã¢ã«âãšã¯ãã¢ã«æ¿åºŠãæå³ã
ãïŒã§æº¶åºããã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶
åºããç»åãšããŠæ¡åãããã ãã®ã€ãªã³äº€æäœåŠçãå ·äœçã«èª¬æããã°ã
äžèšæ²æŸ±ç©åã¯ç²æ«ã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã
奜ãŸããã¯PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã«æº¶è§£
ãããããã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡å
ããã€ãªã³äº€æäœã«ã©ã ãééãããéé液ãæ¡
åããããã®ã€ãªã³äº€æäœã¯åç·©è¡æ¶²ã§æŽæµãã
éé液ãšåãããããã®æäœã¯æ°åè¡ã€ãŠãã
ãã 次ãã§ããã®æº¶æ¶²ã0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§
åžéããŠé£å¡©æ¿åºŠã0.2ã¢ã«ã«ãªãããã«èª¿è£œã
ãããã®æº¶æ¶²ãã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ïŒå¥œ
ãŸããã¯ãPHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ïŒã§å¹³
è¡¡åããã€ãªã³äº€æäœã«ã©ã ã«éããŠåžçãã
ããã«ã©ã ãåç·©è¡æ¶²ã§æŽæµããã®ã¡ã0.3ã¢
ã«ã»é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶åºãè¡ãã溶åºæ¶²ãæ¡
åããã 以äžã®ã€ãªã³äº€æäœåŠçã¯ãããæ³ã§è¡ã€ãŠã
ããããŸããäžèšã€ãªã³äº€æäœåŠçæäœã«ãã
ãŠã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããã€ãª
ã³äº€æäœã«åžçããç»åãæ¡åãããããã0.3
ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããã€ãªã³äº€æäœ
ã«åžçããç»åãšåé¢ããæäœãè¡ã€ãŠã0.3ã¢
ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶åºããç»åãæ¡åããæ¹
æ³ãè¡ãããšãã§ããã 次ãã§ãäžèšã®ããã«ããŠåŸããã溶åºæ¶²ãã
éæåã¯éå€éçã«ãããæ¿çž®ãè±å¡©ã也ç¥ã
ãã°ãç®çã®å¶çæ§ç©è³ªTFâ133bãåŸãããã æ¯ãããŠåŸãããTFâ133bã¯æ¬¡ã®ããšãç©æ§
ãæããã (ã€) çœç°è²ãæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°ŽåçããšãŒã«ãªã
ãçµç¯åçãã¶ã«ã³ãŒã180ç现èã®å¢æ®ãé»
æ¢ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ããã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»
ãã³ããã³ãŒã³ãã¯ãããã«ã ãé ¢é žãšãã«ã
ãžãšãã«ãšãŒãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ïŒ2960ã2930ïŒ1670ã1640ïŒ1550ïŒ
1440ã1380ïŒ1240ïŒ1140ã1000åã³820cm-1ã®
è¿åã«åžå垯ãæããïŒç¬¬ïŒå³ïŒã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€ç·åžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã270ã280nmã®è¿å
ã«ã·ãšã«ããŒã瀺ãïŒç¬¬ïŒå³ïŒã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®ç»
é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ21mmÏÃ
400mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒã§
åç»ãããšã260nmã®çŽ«å€ç·åžå 床枬å®ã«ãã
ãŠã¯ãã€ãã»ããªãŠã ééä»è¿ãã170mlä»è¿
ã«ãããŠåžå垯ãæããããšããŒã«ç¡«é žæ³ã«ã
ã490nmã®åžå 床枬å®ã«ãããŠã¯ãã€ãã»ããª
ãŠã ééä»è¿ãã150mlä»è¿ã«ãããŠåžå垯ã
æãããïŒç¬¬ïŒå³ïŒã (ã) TSKâGEL  3000SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿ
ã®åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ã
ãé«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®
0.1ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒ
ã¯ã220nmã®çŽ«å€ç·åžå 床枬å®ã«ãããŠã¯æº¶åª
å 端éšåã49ã50åä»è¿ã«ãããŠããŒã¯ãæ
ãã260nmã§ã¯æº¶åºå 端éšåã38ã39åã52å
ä»è¿ã«ãããŠããŒã¯ãæããïŒç¬¬ïŒå³ïŒã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«ç¡«é žåå¿ãã¢
ã³ã¹ãã³ç¡«é žåå¿ãã€ã³ããŒã«å¡©é žåå¿ãããŠ
ãªã€ãŒã»ããªãªã³åå¿ã¯éœæ§ããã³ãããªã³å
å¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ31.1ïŒ ã38.5ïŒ ïŒïŒšïŒ3.9ïŒ ã5.2ïŒ ïŒ
ïŒ3.4ïŒ ã4.7ïŒ ïŒã«ïŒ ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯çŽ
19.0ïŒ ã24.5ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ã
ãŠãªã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯
çŽ12.9ïŒ ã22.9ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§
ããã æ¬çºæã®å¶çæ§ç©è³ªTFâ133bã®è¬çäœçšã¯æ¬¡
ã®ãšããã§ããã (1) å ç«è³ŠæŽ»äœçš äžçŸ€ïŒå¹ã®ïŒ©âCRç³»ããŠã¹ãçšããççé£å¡©
æ°Ž0.2mlã«æº¶è§£ãããTFâ133bããè ¹è å æäžã
ããæäž24æéåŸã«Perikan Drawing
Ink17BlackïŒã®ãŠã³ã¿ãŒã»ã¯ã°ããŒç€Ÿè£œïŒïŒmlãš
ãŒã©ãã³ïŒïŒ å«æççé£å¡©æ°ŽïŒmlãæ··åããŠèª¿è£œ
ããã«ãŒãã³æµ®é液0.2mlãããŠã¹å°Ÿéèãã泚
å ¥ããæ³šå ¥åŸïŒïŒïŒïŒ10ããã³15ååŸã«çŒçª©ãã
ãããªã³è¢«èŠãããã¯ãªããæ¯çŽ°ç®¡ãçšããŠè¡æ¶²
0.02mlãæ¡åããçŽã¡ã«0.1ïŒ çé žãããªãŠã æ°Ž
溶液1.6mlã«åžé溶è¡ããããããæ³¢é·675nmã§
æ¯è²ã貧é£ä¿æ°ïŒphagocytotic indexïŒïŒïŒ«å€ã
Halpernãã®æ°åŒã«ããæ±ããã ãŸãå¯Ÿç §çŸ€ã«ã¯ççé£å¡©æ°Ž0.2mlãæäžããã ïŒlogCoâlogCïŒïœâto ïŒCoïŒtoæã®è¡äžçæ«éãïŒïœæã®è¡äžç
æ«éïŒ ãã®çµæã¯è¡šâïŒã®ãšããã§ããã
ããèäœã®é€å»ã¯åžžæ³ãäŸãã°é å¿åé¢ããã€ã
ãã¹ãŒããŒã»ã«çã®éå©å€ãçšããéæ³ãæ¡
çšã§ããããç¹ã«é å¿åé¢æ³ã¯æäœãèã®é€å»åºŠ
åãäžæž 液ã®ååŸéã®ç¹ã§å¥œãŸãããåãèäœã®
é€å»ã¯ãã®æ®µéã§è¡ãªãã®ã奜ãŸããã次ã®(c)ã®
æäœã«ãããŠé€å»ããŠãããã (c) å¶çæ§ç©è³ªTFâ133bã®æ¡å äžã§åŸãããäžæž 液åã¯å¹é€æ¶²ã«èŠªæ°Žæ§ææ©æº¶
åªãå ããŠãçããæ²æŸ±ç©ãæ¡åããããã®éã®
äžæž 液åã¯å¹é€æ¶²ã¯PHïŒãïŒã«èª¿æŽããã®ã奜ãŸ
ããã芪氎æ§ææ©æº¶åªãšããŠã¯ãäŸãã°ãšã¿ããŒ
ã«ãã¡ã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡ãã¢ã»ãã³çã®
ã±ãã³é¡ãæããããããã¢ã«ã³ãŒã«é¡ç¹ã«ãšã¿
ããŒã«ãæãããçµæãäžããããã®èŠªæ°Žæ§ææ©
溶åªã¯ãã®æ¿åºŠã30ã70ïŒ ã奜ãŸããã¯50ã70ïŒ
ã«ãªãããã«æ·»å ããã®ã奜é©ã§ããã芪氎æ§æ
æ©æº¶åªãå ããåŸãäœæž©ã奜ãŸããã¯çŽïŒâã®æž©
床ã§æ°æéãæ°æ¥éæŸåž¯çœ®ããæ²æŸ±ç©ã®çæãå®
çµãããã ãã®ããã«ããŠçããæ²æŸ±ç©ããã«ã³ããŒã·ãš
ã³ãé å¿åé¢ãéçã®éåžžã®æäœã§åé¢ããã 次ãã§ããã®æ²æŸ±ç©ã«10ã15åéã®æ°Žåã¯ãªã³
é žç·©è¡æ¶²ïŒé£å¡©ïŒãå ããçããæ°Žäžæº¶ç©ãé å¿
åé¢ãéçã®éåžžã®æ¹æ³ã§é€å»ãããå¹é€æ¶²ã
䜿çšãããšãã¯ãã®åŠçã«ããèäœãé€å»ãã
ããæŽã«æ¯ãããŠåŸãããæ°Žå¯æº¶æåã®åé¢æ¶²ã
ãã®ãŸãŸã€ãªã³äº€æäœåŠçã«ä»ããããšãã§ãã
ãããã®æ°Žå¯æº¶æåãéæåã¯éå€éãããã®
å 液ãåã¯ãæŽã«åçµä¹Ÿç¥çã«ãã€ãŠä¹Ÿç¥ããŠç²
æ«ãã€ãªã³äº€æäœåŠçã«ä»ããŠãããã æ¯ãããŠåŸãããäžèšæ°Žå¯æº¶æååã¯éæåã¯
éå€éããå 液æåã«ã€ããŠã€ãªäº€æäœåŠçã
ããã€ãªã³äº€æäœãšããŠã¯ã匱塩åºæ§ã€ãªã³äº€æ
äœåã¯åå篩æ§ã䜵æãããã®ã䜿çšããã®ã奜
ãŸãããäŸãã°ãžãšãã«ã¢ãããšãã«âã»ãã¢ã
ãã¯ã¹ïŒ¡â50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒã奜é©
ã«äœ¿çšããããã€ãªã³äº€æäœåŠçã«ãããŠãå¶ç
æ§ç©è³ªTFâ133bã¯ã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²
ïŒãã®æ现æžã§âã¢ã«âãšã¯ãã¢ã«æ¿åºŠãæå³ã
ãïŒã§æº¶åºããã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶
åºããç»åãšããŠæ¡åãããã ãã®ã€ãªã³äº€æäœåŠçãå ·äœçã«èª¬æããã°ã
äžèšæ²æŸ±ç©åã¯ç²æ«ã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã
奜ãŸããã¯PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã«æº¶è§£
ãããããã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡å
ããã€ãªã³äº€æäœã«ã©ã ãééãããéé液ãæ¡
åããããã®ã€ãªã³äº€æäœã¯åç·©è¡æ¶²ã§æŽæµãã
éé液ãšåãããããã®æäœã¯æ°åè¡ã€ãŠãã
ãã 次ãã§ããã®æº¶æ¶²ã0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§
åžéããŠé£å¡©æ¿åºŠã0.2ã¢ã«ã«ãªãããã«èª¿è£œã
ãããã®æº¶æ¶²ãã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ïŒå¥œ
ãŸããã¯ãPHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ïŒã§å¹³
è¡¡åããã€ãªã³äº€æäœã«ã©ã ã«éããŠåžçãã
ããã«ã©ã ãåç·©è¡æ¶²ã§æŽæµããã®ã¡ã0.3ã¢
ã«ã»é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶åºãè¡ãã溶åºæ¶²ãæ¡
åããã 以äžã®ã€ãªã³äº€æäœåŠçã¯ãããæ³ã§è¡ã€ãŠã
ããããŸããäžèšã€ãªã³äº€æäœåŠçæäœã«ãã
ãŠã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããã€ãª
ã³äº€æäœã«åžçããç»åãæ¡åãããããã0.3
ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããã€ãªã³äº€æäœ
ã«åžçããç»åãšåé¢ããæäœãè¡ã€ãŠã0.3ã¢
ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶åºããç»åãæ¡åããæ¹
æ³ãè¡ãããšãã§ããã 次ãã§ãäžèšã®ããã«ããŠåŸããã溶åºæ¶²ãã
éæåã¯éå€éçã«ãããæ¿çž®ãè±å¡©ã也ç¥ã
ãã°ãç®çã®å¶çæ§ç©è³ªTFâ133bãåŸãããã æ¯ãããŠåŸãããTFâ133bã¯æ¬¡ã®ããšãç©æ§
ãæããã (ã€) çœç°è²ãæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°ŽåçããšãŒã«ãªã
ãçµç¯åçãã¶ã«ã³ãŒã180ç现èã®å¢æ®ãé»
æ¢ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ããã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»
ãã³ããã³ãŒã³ãã¯ãããã«ã ãé ¢é žãšãã«ã
ãžãšãã«ãšãŒãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ïŒ2960ã2930ïŒ1670ã1640ïŒ1550ïŒ
1440ã1380ïŒ1240ïŒ1140ã1000åã³820cm-1ã®
è¿åã«åžå垯ãæããïŒç¬¬ïŒå³ïŒã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€ç·åžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã270ã280nmã®è¿å
ã«ã·ãšã«ããŒã瀺ãïŒç¬¬ïŒå³ïŒã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®ç»
é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ21mmÏÃ
400mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒã§
åç»ãããšã260nmã®çŽ«å€ç·åžå 床枬å®ã«ãã
ãŠã¯ãã€ãã»ããªãŠã ééä»è¿ãã170mlä»è¿
ã«ãããŠåžå垯ãæããããšããŒã«ç¡«é žæ³ã«ã
ã490nmã®åžå 床枬å®ã«ãããŠã¯ãã€ãã»ããª
ãŠã ééä»è¿ãã150mlä»è¿ã«ãããŠåžå垯ã
æãããïŒç¬¬ïŒå³ïŒã (ã) TSKâGEL  3000SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿ
ã®åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ã
ãé«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®
0.1ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒ
ã¯ã220nmã®çŽ«å€ç·åžå 床枬å®ã«ãããŠã¯æº¶åª
å 端éšåã49ã50åä»è¿ã«ãããŠããŒã¯ãæ
ãã260nmã§ã¯æº¶åºå 端éšåã38ã39åã52å
ä»è¿ã«ãããŠããŒã¯ãæããïŒç¬¬ïŒå³ïŒã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«ç¡«é žåå¿ãã¢
ã³ã¹ãã³ç¡«é žåå¿ãã€ã³ããŒã«å¡©é žåå¿ãããŠ
ãªã€ãŒã»ããªãªã³åå¿ã¯éœæ§ããã³ãããªã³å
å¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ31.1ïŒ ã38.5ïŒ ïŒïŒšïŒ3.9ïŒ ã5.2ïŒ ïŒ
ïŒ3.4ïŒ ã4.7ïŒ ïŒã«ïŒ ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯çŽ
19.0ïŒ ã24.5ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ã
ãŠãªã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯
çŽ12.9ïŒ ã22.9ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§
ããã æ¬çºæã®å¶çæ§ç©è³ªTFâ133bã®è¬çäœçšã¯æ¬¡
ã®ãšããã§ããã (1) å ç«è³ŠæŽ»äœçš äžçŸ€ïŒå¹ã®ïŒ©âCRç³»ããŠã¹ãçšããççé£å¡©
æ°Ž0.2mlã«æº¶è§£ãããTFâ133bããè ¹è å æäžã
ããæäž24æéåŸã«Perikan Drawing
Ink17BlackïŒã®ãŠã³ã¿ãŒã»ã¯ã°ããŒç€Ÿè£œïŒïŒmlãš
ãŒã©ãã³ïŒïŒ å«æççé£å¡©æ°ŽïŒmlãæ··åããŠèª¿è£œ
ããã«ãŒãã³æµ®é液0.2mlãããŠã¹å°Ÿéèãã泚
å ¥ããæ³šå ¥åŸïŒïŒïŒïŒ10ããã³15ååŸã«çŒçª©ãã
ãããªã³è¢«èŠãããã¯ãªããæ¯çŽ°ç®¡ãçšããŠè¡æ¶²
0.02mlãæ¡åããçŽã¡ã«0.1ïŒ çé žãããªãŠã æ°Ž
溶液1.6mlã«åžé溶è¡ããããããæ³¢é·675nmã§
æ¯è²ã貧é£ä¿æ°ïŒphagocytotic indexïŒïŒïŒ«å€ã
Halpernãã®æ°åŒã«ããæ±ããã ãŸãå¯Ÿç §çŸ€ã«ã¯ççé£å¡©æ°Ž0.2mlãæäžããã ïŒlogCoâlogCïŒïœâto ïŒCoïŒtoæã®è¡äžçæ«éãïŒïœæã®è¡äžç
æ«éïŒ ãã®çµæã¯è¡šâïŒã®ãšããã§ããã
ãè¡šã
è¡šâïŒããæãããªããšãã察ç
§çŸ€ã«æ¯ããŠã
æ¬çºæã®TFâ133bæäžçŸ€ã¯ç¶²å ç³»ãã¯ããã¢ãŒ
ãžã掻æ§åãããæ£åžžããŠã¹ã®çŽ°èæ§å ç«ãå¢å€§
ããã (2) å¶çäœçš (a) ãšãŒã«ãªããè ¹æ°Žåè «çã«æŒããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ãäžçŸ€ïŒå¹ïŒã«ãšãŒ
ã«ãªããè ¹æ°Žåç现èïŒÃ105åïŒå¹ãè ¹è å æ¥
çš®ããã次ãã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ããã
TFâ133bããç现èæ¥çš®åŸïŒæ¥ç®ãïŒãïŒæ¥ç®
è¿ïŒæ¥ïŒåèšïŒæ¥éè ¹è å ã«æäžããããŸãå¯Ÿç §
矀ã«ã¯åéã®ççé£å¡©æ°Žãäžèšãšåæ§ã«æäžã
ãã ãã®çµæãè¡šâïŒã«ç€ºãã ïŒïŒ£ïŒTFâ133bæäžçŸ€ã®å¹³åçåæ¥æ°ïŒå¯Ÿç §çŸ€ã®å¹³å
çåæ¥æ° Ã100ïŒïŒ ïŒ
æ¬çºæã®TFâ133bæäžçŸ€ã¯ç¶²å ç³»ãã¯ããã¢ãŒ
ãžã掻æ§åãããæ£åžžããŠã¹ã®çŽ°èæ§å ç«ãå¢å€§
ããã (2) å¶çäœçš (a) ãšãŒã«ãªããè ¹æ°Žåè «çã«æŒããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ãäžçŸ€ïŒå¹ïŒã«ãšãŒ
ã«ãªããè ¹æ°Žåç现èïŒÃ105åïŒå¹ãè ¹è å æ¥
çš®ããã次ãã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ããã
TFâ133bããç现èæ¥çš®åŸïŒæ¥ç®ãïŒãïŒæ¥ç®
è¿ïŒæ¥ïŒåèšïŒæ¥éè ¹è å ã«æäžããããŸãå¯Ÿç §
矀ã«ã¯åéã®ççé£å¡©æ°Žãäžèšãšåæ§ã«æäžã
ãã ãã®çµæãè¡šâïŒã«ç€ºãã ïŒïŒ£ïŒTFâ133bæäžçŸ€ã®å¹³åçåæ¥æ°ïŒå¯Ÿç §çŸ€ã®å¹³å
çåæ¥æ° Ã100ïŒïŒ ïŒ
ãè¡šã
è¡šâïŒããæãããªããã«ã察ç
§çŸ€ã«æ¯ãã
TFâ133bæäžçŸ€ã«ã¯å»¶åœå¹æãèªãããã40æ¥
ç®ã«ãããŠå®å šæ²»çããŠã¹ãå€ãã¿ãããã (b) ãšãŒã«ãªããçµç¯åè «çã«æŒããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ãïŒçŸ€ïŒå¹ïŒã«ãšãŒ
ã«ãªããç现èïŒÃ106åïŒå¹ãè äžéšç®äžã«ç§»
æ®ããã 次ãã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ãããTFâ
133bãç现è移æ®åŸïŒæ¥ç®ããã³ïŒæ¥ç®ããïŒ
æ¥ç®è¿ïŒæ¥ïŒåèšïŒæ¥éè ¹è å ã«æäžããããŸã
å¯Ÿç §çŸ€ã«ã¯ãåéã®ççé£å¡©æ°Žãäžèšãšåæ§ã«æ
äžãããç现è移æ®åŸã14æ¥ç®ã«è «çééã枬å®
ããããã®çµæãè¡šâïŒã«ç€ºããå°ãè «çééã¯
è «çéšäœã®é·åŸ(a)mmããã³çåŸ(b)mmããã®ã¹ã«ãŠ
枬å®ãã次åŒã«ãã€ãŠæ±ããã è «çééïŒïœÃb2ïŒïŒïŒmgïŒ
TFâ133bæäžçŸ€ã«ã¯å»¶åœå¹æãèªãããã40æ¥
ç®ã«ãããŠå®å šæ²»çããŠã¹ãå€ãã¿ãããã (b) ãšãŒã«ãªããçµç¯åè «çã«æŒããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ãïŒçŸ€ïŒå¹ïŒã«ãšãŒ
ã«ãªããç现èïŒÃ106åïŒå¹ãè äžéšç®äžã«ç§»
æ®ããã 次ãã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ãããTFâ
133bãç现è移æ®åŸïŒæ¥ç®ããã³ïŒæ¥ç®ããïŒ
æ¥ç®è¿ïŒæ¥ïŒåèšïŒæ¥éè ¹è å ã«æäžããããŸã
å¯Ÿç §çŸ€ã«ã¯ãåéã®ççé£å¡©æ°Žãäžèšãšåæ§ã«æ
äžãããç现è移æ®åŸã14æ¥ç®ã«è «çééã枬å®
ããããã®çµæãè¡šâïŒã«ç€ºããå°ãè «çééã¯
è «çéšäœã®é·åŸ(a)mmããã³çåŸ(b)mmããã®ã¹ã«ãŠ
枬å®ãã次åŒã«ãã€ãŠæ±ããã è «çééïŒïœÃb2ïŒïŒïŒmgïŒ
ãè¡šã
è¡šâïŒããæãããªããã«ã察ç
§çŸ€ã«æ¯ãã
TFâ133bæäžçŸ€ã«ã¯è «çå¢æ®æå¶å¹æãèªãã
ããã (c) ã¶ã«ã³ãŒã180ç现èã«å¯Ÿããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«ã¶ã«ã³ãŒã180
ç现èïŒÃ105åïŒå¹ãè ¹è å ã«ç§»æ®ããã次ã
ã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ãããTFâ133bãç
现è移æ®åŸïŒæ¥ç®ããè ¹è å ã«ïŒæ¥ïŒåãïŒæ¥é
é£ç¶æäžããããŸããå¯Ÿç §çŸ€ã«ã¯åéã®ççé£å¡©
æ°Žãäžèšãšåæ§ã«é£ç¶æäžããããã®çµæãè¡šâ
ïŒã«ç€ºããïŒïŒ£ã¯(a)ãšåæ§ã«ããŠæ±ããã
TFâ133bæäžçŸ€ã«ã¯è «çå¢æ®æå¶å¹æãèªãã
ããã (c) ã¶ã«ã³ãŒã180ç现èã«å¯Ÿããæè «çå¹æ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«ã¶ã«ã³ãŒã180
ç现èïŒÃ105åïŒå¹ãè ¹è å ã«ç§»æ®ããã次ã
ã§ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ãããTFâ133bãç
现è移æ®åŸïŒæ¥ç®ããè ¹è å ã«ïŒæ¥ïŒåãïŒæ¥é
é£ç¶æäžããããŸããå¯Ÿç §çŸ€ã«ã¯åéã®ççé£å¡©
æ°Žãäžèšãšåæ§ã«é£ç¶æäžããããã®çµæãè¡šâ
ïŒã«ç€ºããïŒïŒ£ã¯(a)ãšåæ§ã«ããŠæ±ããã
ãè¡šã
è¡šâïŒããæãããªããã«ã察ç
§çŸ€ã«æ¯ãã
TFâ133bæäžçŸ€ã«ã¯å»¶åœå¹æãèªããããå®å š
æ²»çããŠã¹ãå€ãã¿ãããã (3) æ¥æ§æ¯æ§ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«æŒããŠãTFâ
133bãéèå ïŒåæäžãããšãã®LD50å€ã¯ïŒ200
mgïŒKgã§ãã€ãã 以äžã®è¬çå®éšã®çµæããæãããªããã«ãæ¬
çºæã®å¶çæ§ç©è³ªTFâ133bã¯å¶çå€ãšããŠæçš
ãªãã®ã§ãããåçš®ã®ççŸæ£ã«äœ¿çšããå¹æãæ
åŸ ããããã®ã§ãããããšãããåºåçã«å¯ŸããŠ
èããå¹æãæåŸ ã§ããã æ¬çºæã®TFâ133bã¯åžžæ³ã«ããçµå£ã泚å°ã
åè¬çã®å€åœ¢ã«ããŠäœ¿çšããããšãã§ãããçµå£
å€ãšããŠã¯çš®ã ã®è³Šåœ¢å€ãå«ãã§ããããã«ãã»
ã«å€ãé å€ãæ£å€ãé¡ç²å€ãšããããšãã§ããã
ãŸãã泚å°å€ãšããŠã¯ç®äžãçèå ãéèå 泚å°
å€ã®ãããã§ããããæžæ¿æ¶²ã溶液ãããã¯äœ¿çš
æ溶解ãããç²æ«çã®å€åœ¢ãçšããããããŸã泚
å°å€ã«ã¯å±æ麻é å€ãå«ãã§ããŠãããã æ¬çºæã®TFâ133bã®æäžéã¯æ£è ã®çç¶ã«å¿
ããŠé©å®éžæãããããäžè¬ã«æ人ã«ãããŠ0.01
ã50mgïŒKgãïŒæ¥ïŒãæ°åã«åãæäžããã®ã奜
ãŸãããæäžæ¹æ³ãšããŠã¯ç®äžãçèå ãéèå
ãããã¯æ£éšãžã®æ³šå°ã«ãã€ãŠãªãããã®ã奜ãŸ
ããã 次ã«æ¬çºæã®å®æœäŸãæããŠèª¬æããã å®æœäŸ ïŒ (1) ïŒå®¹ã®ã¹ã¯ãªãŠãŒãã€ããä»å¹é€ç¶15æ¬
ã«ãããããïŒæ¬ã«ã€ãããªããã±ãŒã¹ã»ãã
ãã³34ïœããã¢ã€ãã³ã»ãããã³ïŒïœãããã
ãªãŒã¹ã»ãããã³20ïœããã¬ã€ã³ã»ããŒãã»ã€
ã³ããŠãŒãžãšã³70ïœãã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯
ãïŒïœãé£å¡©15ïœãã°ã«ã³ãŒã¹12ïœãã©ã¯ããŒ
ã¹10ïœãâã·ã¹ãã³0.5ïœãäºç¡«é žãœãŒã0.2
ïœãããªã°ãªã³ã¬ãŒãã»ãããªãŠã 1.0ïœãå¯
倩1.4ïœãå ãPHïŒã«èª¿æŽããå¹å°ïŒãå ¥ãã
120âã§15åéå å§æ» èããã®ã¡ããã ã¡ã«æ°Ž
å·å·åŽããäºãåçµæã®å¹å°ã§åå¹é€ããŠãã
ãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TFâ031
ïŒåŸ®å·¥ç åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·ïŒã®åå¹
é€æ¶²ãå¹é€ç¶ïŒæ¬ã«ã€ã100mlã®å²åã§æ» èæ¡
件äžã«æ¥çš®ãã37âã®ãµåµåšäžã§48æéé眮å¹
é€ãè¡ããå¹é€çµäºåŸãïŒâã§4000r.p.mïŒ20
åéãã®å¹é€æ¶²ãé å¿åé¢ãèäœãé€å»ããŠäž
æž æ¶²çŽ27ãåŸãã (2) (1)ã§åŸãäžæž 液ã«ïŒâã§æ¹æäžã«ãšã¿ããŒã«
40ãå ããç¡å®åœ¢ã®æ²æŸ±ç©ãå®å šã«æ²æŸ±ãã
ãŸã§äœæž©å®€ã§æŸçœ®ãããã€ãã§ïŒâã§ã6000r.
p.mïŒ15åéé å¿åé¢ãæ²æŸ±ç©ãæ¡åãããšã¿
ããŒã«ã§æŽæµããæžå§ä¹Ÿç¥ããŠçŽ60ïœã®ç²ç²æ«
ãåŸãã (3) (2)ã§åŸãããç²æ«44.2ïœãé£å¡©æ¿åºŠ0.3ã¢ã«
ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²1.2ã«æº¶è§£ã
ããæµ®éããäžæº¶ç©ããã€ããã¹ãŒããŒã»ã«ã
çšããŠå»ããåŸããã液ããé£å¡©æ¿åºŠ0.3
ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡å
ãããžãšãã«ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡â
50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ500mlã®ã«ã©ã
ïŒçŽåŸ33cmïŒã«ããéé液ãæ¡åãããã«ã©ã
ã¯é£å¡©æ¿åºŠ0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©
è¡æ¶²ã§æŽæµããæŽæµæ¶²ãšäžèšéé液ãåãããŠ
1.67ã®æº¶æ¶²ãåŸããããããåã³é£å¡©æ¿åºŠ
0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡
åãããžãšãã«ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡
â50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ400mlã®ã«ã©ã
ïŒçŽåŸïŒcmïŒã«ããéé液1.68ãåŸããã«ã©
ã ã¯é£å¡©æ¿åºŠ0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é ž
ç·©è¡æ¶²ã§æŽæµããŠãæŽæµæ¶²1.64ãåŸããéé
液ããã³æŽæµæ¶²ãåãããŠãããã«PHïŒã®
0.025ã¢ã«ãªã³é žç·©è¡æ¶²ãå ããé£å¡©æ¿åºŠ0.2ã¢
ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²4.98ãšã
ãããã®æº¶æ¶²ããé£å¡©æ¿åºŠ0.2ã¢ã«ã®PHïŒã®
0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åãããžãšãã«
ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡â50ïŒãã¢ã«ã
ã·ã¢ç€Ÿè£œåååïŒ500mlã®ã«ã©ã ïŒçŽåŸïŒcmïŒ
ã«ãããé£å¡©æ¿åºŠ0.2ã¢ã«ã®PHïŒã®0.025ã¢ã«ãª
ã³é žç·©è¡æ¶²ïŒã§ã«ã©ã ãæŽæµããåŸãé£å¡©æ¿
床0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ïŒ
ãæµå ¥ãã溶åºæ¶²ãæ¡åããããã®æº¶åºæ¶²ãé
å€éã·ã¹ãã ïŒäœ¿çšãã€ã«ã¿ãŒïŒæ±æŽãŠã«ã
ã©ãã€ã«ã¿ãŒukâ10ïŒãçšããŠæ¿çž®ããã³è±
å¡©ããåŸãæŽã«ãã»ãã¢ããã¯ã¹ïŒ§â25ã«ã©ã
ãçšããŠè±å¡©ãã掻æ§çã«ãŠè±è²ãããåŸãå
çµä¹Ÿç¥ããçœç°è²ãæ·¡è€è²ã®TFâ133bã®ç²æ«
590mgãåŸãã å®æœäŸ ïŒ å®æœäŸïŒã§åŸãããç²æ«ïŒmgããã€ã¢ã«ç¶ã«å
å¡«ãããããã¯äœ¿çšææ» èççé£å¡©æ°Žåã¯ãªãã«
ã€ã³0.5ïŒ å«æ溶液çã§æº¶è§£ã泚å°æ¶²ãšããŠçšã
ãã
TFâ133bæäžçŸ€ã«ã¯å»¶åœå¹æãèªããããå®å š
æ²»çããŠã¹ãå€ãã¿ãããã (3) æ¥æ§æ¯æ§ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«æŒããŠãTFâ
133bãéèå ïŒåæäžãããšãã®LD50å€ã¯ïŒ200
mgïŒKgã§ãã€ãã 以äžã®è¬çå®éšã®çµæããæãããªããã«ãæ¬
çºæã®å¶çæ§ç©è³ªTFâ133bã¯å¶çå€ãšããŠæçš
ãªãã®ã§ãããåçš®ã®ççŸæ£ã«äœ¿çšããå¹æãæ
åŸ ããããã®ã§ãããããšãããåºåçã«å¯ŸããŠ
èããå¹æãæåŸ ã§ããã æ¬çºæã®TFâ133bã¯åžžæ³ã«ããçµå£ã泚å°ã
åè¬çã®å€åœ¢ã«ããŠäœ¿çšããããšãã§ãããçµå£
å€ãšããŠã¯çš®ã ã®è³Šåœ¢å€ãå«ãã§ããããã«ãã»
ã«å€ãé å€ãæ£å€ãé¡ç²å€ãšããããšãã§ããã
ãŸãã泚å°å€ãšããŠã¯ç®äžãçèå ãéèå 泚å°
å€ã®ãããã§ããããæžæ¿æ¶²ã溶液ãããã¯äœ¿çš
æ溶解ãããç²æ«çã®å€åœ¢ãçšããããããŸã泚
å°å€ã«ã¯å±æ麻é å€ãå«ãã§ããŠãããã æ¬çºæã®TFâ133bã®æäžéã¯æ£è ã®çç¶ã«å¿
ããŠé©å®éžæãããããäžè¬ã«æ人ã«ãããŠ0.01
ã50mgïŒKgãïŒæ¥ïŒãæ°åã«åãæäžããã®ã奜
ãŸãããæäžæ¹æ³ãšããŠã¯ç®äžãçèå ãéèå
ãããã¯æ£éšãžã®æ³šå°ã«ãã€ãŠãªãããã®ã奜ãŸ
ããã 次ã«æ¬çºæã®å®æœäŸãæããŠèª¬æããã å®æœäŸ ïŒ (1) ïŒå®¹ã®ã¹ã¯ãªãŠãŒãã€ããä»å¹é€ç¶15æ¬
ã«ãããããïŒæ¬ã«ã€ãããªããã±ãŒã¹ã»ãã
ãã³34ïœããã¢ã€ãã³ã»ãããã³ïŒïœãããã
ãªãŒã¹ã»ãããã³20ïœããã¬ã€ã³ã»ããŒãã»ã€
ã³ããŠãŒãžãšã³70ïœãã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯
ãïŒïœãé£å¡©15ïœãã°ã«ã³ãŒã¹12ïœãã©ã¯ããŒ
ã¹10ïœãâã·ã¹ãã³0.5ïœãäºç¡«é žãœãŒã0.2
ïœãããªã°ãªã³ã¬ãŒãã»ãããªãŠã 1.0ïœãå¯
倩1.4ïœãå ãPHïŒã«èª¿æŽããå¹å°ïŒãå ¥ãã
120âã§15åéå å§æ» èããã®ã¡ããã ã¡ã«æ°Ž
å·å·åŽããäºãåçµæã®å¹å°ã§åå¹é€ããŠãã
ãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TFâ031
ïŒåŸ®å·¥ç åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·ïŒã®åå¹
é€æ¶²ãå¹é€ç¶ïŒæ¬ã«ã€ã100mlã®å²åã§æ» èæ¡
件äžã«æ¥çš®ãã37âã®ãµåµåšäžã§48æéé眮å¹
é€ãè¡ããå¹é€çµäºåŸãïŒâã§4000r.p.mïŒ20
åéãã®å¹é€æ¶²ãé å¿åé¢ãèäœãé€å»ããŠäž
æž æ¶²çŽ27ãåŸãã (2) (1)ã§åŸãäžæž 液ã«ïŒâã§æ¹æäžã«ãšã¿ããŒã«
40ãå ããç¡å®åœ¢ã®æ²æŸ±ç©ãå®å šã«æ²æŸ±ãã
ãŸã§äœæž©å®€ã§æŸçœ®ãããã€ãã§ïŒâã§ã6000r.
p.mïŒ15åéé å¿åé¢ãæ²æŸ±ç©ãæ¡åãããšã¿
ããŒã«ã§æŽæµããæžå§ä¹Ÿç¥ããŠçŽ60ïœã®ç²ç²æ«
ãåŸãã (3) (2)ã§åŸãããç²æ«44.2ïœãé£å¡©æ¿åºŠ0.3ã¢ã«
ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²1.2ã«æº¶è§£ã
ããæµ®éããäžæº¶ç©ããã€ããã¹ãŒããŒã»ã«ã
çšããŠå»ããåŸããã液ããé£å¡©æ¿åºŠ0.3
ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡å
ãããžãšãã«ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡â
50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ500mlã®ã«ã©ã
ïŒçŽåŸ33cmïŒã«ããéé液ãæ¡åãããã«ã©ã
ã¯é£å¡©æ¿åºŠ0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©
è¡æ¶²ã§æŽæµããæŽæµæ¶²ãšäžèšéé液ãåãããŠ
1.67ã®æº¶æ¶²ãåŸããããããåã³é£å¡©æ¿åºŠ
0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡
åãããžãšãã«ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡
â50ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ400mlã®ã«ã©ã
ïŒçŽåŸïŒcmïŒã«ããéé液1.68ãåŸããã«ã©
ã ã¯é£å¡©æ¿åºŠ0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é ž
ç·©è¡æ¶²ã§æŽæµããŠãæŽæµæ¶²1.64ãåŸããéé
液ããã³æŽæµæ¶²ãåãããŠãããã«PHïŒã®
0.025ã¢ã«ãªã³é žç·©è¡æ¶²ãå ããé£å¡©æ¿åºŠ0.2ã¢
ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²4.98ãšã
ãããã®æº¶æ¶²ããé£å¡©æ¿åºŠ0.2ã¢ã«ã®PHïŒã®
0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åãããžãšãã«
ã¢ãããšãã«ã»ãã¢ããã¯ã¹ïŒ¡â50ïŒãã¢ã«ã
ã·ã¢ç€Ÿè£œåååïŒ500mlã®ã«ã©ã ïŒçŽåŸïŒcmïŒ
ã«ãããé£å¡©æ¿åºŠ0.2ã¢ã«ã®PHïŒã®0.025ã¢ã«ãª
ã³é žç·©è¡æ¶²ïŒã§ã«ã©ã ãæŽæµããåŸãé£å¡©æ¿
床0.3ã¢ã«ã®PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ïŒ
ãæµå ¥ãã溶åºæ¶²ãæ¡åããããã®æº¶åºæ¶²ãé
å€éã·ã¹ãã ïŒäœ¿çšãã€ã«ã¿ãŒïŒæ±æŽãŠã«ã
ã©ãã€ã«ã¿ãŒukâ10ïŒãçšããŠæ¿çž®ããã³è±
å¡©ããåŸãæŽã«ãã»ãã¢ããã¯ã¹ïŒ§â25ã«ã©ã
ãçšããŠè±å¡©ãã掻æ§çã«ãŠè±è²ãããåŸãå
çµä¹Ÿç¥ããçœç°è²ãæ·¡è€è²ã®TFâ133bã®ç²æ«
590mgãåŸãã å®æœäŸ ïŒ å®æœäŸïŒã§åŸãããç²æ«ïŒmgããã€ã¢ã«ç¶ã«å
å¡«ãããããã¯äœ¿çšææ» èççé£å¡©æ°Žåã¯ãªãã«
ã€ã³0.5ïŒ å«æ溶液çã§æº¶è§£ã泚å°æ¶²ãšããŠçšã
ãã
第ïŒå³ã¯ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TF
â031ã®åœ¢æ ã瀺ãé¡åŸ®é¡åçã第ïŒå³ã¯æ¬çºæ
ã®å¶çæ§ç©è³ªTFâ133bã®èµ€å€ç·åžåã¹ãã¯ã
ã«ã第ïŒå³ã¯åç©è³ªã®çŽ«å€ç·åžåã¹ãã¯ãã«ã第
ïŒå³ã¯åç©è³ªãã»ãã¢ããã¯ã¹ïŒ§â200ãçšããŠ
ã²ã«éãããšãã®æº¶åºãã¿ãŒã³ã第ïŒå³ã¯åç©
質ã®é«é液äœã¯ãããã°ã©ã ã瀺ãã
â031ã®åœ¢æ ã瀺ãé¡åŸ®é¡åçã第ïŒå³ã¯æ¬çºæ
ã®å¶çæ§ç©è³ªTFâ133bã®èµ€å€ç·åžåã¹ãã¯ã
ã«ã第ïŒå³ã¯åç©è³ªã®çŽ«å€ç·åžåã¹ãã¯ãã«ã第
ïŒå³ã¯åç©è³ªãã»ãã¢ããã¯ã¹ïŒ§â200ãçšããŠ
ã²ã«éãããšãã®æº¶åºãã¿ãŒã³ã第ïŒå³ã¯åç©
質ã®é«é液äœã¯ãããã°ã©ã ã瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â133bçç£èãå¹é€ãããã®å¹é€æ¶²ããåŸãã
ã次ã®æ§ç¶ãæããå¶çæ§ç©è³ªTFâ133bã (ã€) çœç°è²ãæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°ŽåçããšãŒã«ãªã
ãçµç¯åçãã¶ã«ã³ãŒã180ç现èã®å¢æ®ãé»
æ¢ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ããã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»
ãã³ããã³ãŒã³ãã¯ãããã«ã ãé ¢é žãšãã«ã
ãžãšãã«ãšãŒãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ïŒ2960ã2930ïŒ1670ã1640ïŒ1550ïŒ
1440ã1380ïŒ1240ïŒ1140ã1000åã³820cm-1ã®
è¿åã«åžå垯ãæããã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€ç·åžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã270ã280nmã®è¿å
ã«ã·ãšã«ããŒã瀺ãã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®ç»
é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ21mmÏÃ
400mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒã§
åç»ãããš260nmã®çŽ«å€ç·åžå 床枬å®ã«ãããŠ
ã¯ããã€ãã»ããªãŠã ééä»è¿ãã170mlä»è¿
ã«ãããŠåžå垯ãæããããšããŒã«ç¡«é žæ³ã«ã
ã490nmã®åžå 床枬å®ã«ãããŠã¯ãã€ãã»ããª
ãŠã ééä»è¿ãã150mlä»è¿ã«ãããŠåžå垯ã
æããã (ã) TSKâGEL G3000SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿã®
åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ãã
é«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®0.1
ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒã¯ã
220nmã®çŽ«å€ç·åžå 床枬å®ã«ãããŠã¯ã溶åªå
端éšåã49ã50åä»è¿ã«ãããŠããŒã¯ãæãã
260nmã§ã¯æº¶åªå 端éšåã38ã39åã52åä»è¿
ã«ãããŠããŒã¯ãæããã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«ç¡«é žåå¿ãã¢
ã³ã¹ãã³ç¡«é žåå¿ãã€ã³ããŒã«å¡©é žåå¿ãããŠ
ãªã€ãŒã»ããªãªã³åå¿ã¯éœæ§ããã³ãããªã³å
å¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ31.1ïŒ ã38.5ïŒ ïŒïŒšïŒ3.9ïŒ ã5.2ïŒ ïŒ
ïŒ3.4ïŒ ã4.7ïŒ ïŒã«ïŒ ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯çŽ
19.0ïŒ ã24.5ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ã
ãŠãªã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯
çŽ12.9ïŒ ã22.9ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§
ããã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â133bçç£èãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿
ã ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ª
TFâ133bã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â133bçç£èãå¹é€ããŠåŸãå¹é€æ¶²åã¯äžæž 液
ã«èŠªæ°Žæ§ææ©æº¶åªãå ããŠçããæ²æŸ±ç©ãæ¡å
ãããã®æ²æŸ±ç©ã®æ°Žå¯æº¶æåããææã«ããéæ
åã¯éå€éããåŸã€ãªã³äº€æäœåŠçããŠã0.2
ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶åºããã0.3ã¢ã«é£å¡©
ãªã³é žç·©è¡æ¶²ã§æº¶åºããç»åãæ¡åããããšãç¹
城ãšããå¶çæ§ç©è³ªTFâ133bã®è£œé æ³ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â133bçç£èãå¹é€ããŠåŸãå¹é€æ¶²åã¯äžæž 液
ã«èŠªæ°Žæ§ææ©æº¶åªãå ããŠçããæ²æŸ±ç©ãæ¡å
ãããã®æ²æŸ±ç©ã®æ°Žå¯æº¶æåããææã«ããéæ
åã¯éå€éããåŸããã0.3ã¢ã«é£å¡©ãªã³é žç·©
è¡æ¶²ãšãªãã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡å
ããã€ãªã³äº€æäœã§åŠçããŠéé液ãæ¡åãã次
ãã§ããã0.2ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åã
ãã€ãªã³äº€æäœã§åŠçãã0.2ã¢ã«é£å¡©ãªã³é žç·©
è¡æ¶²ã§æº¶åºããã0.3ã¢ã«é£å¡©ãªã³é žç·©è¡æ¶²ã§æº¶
åºããç»åãæ¡åããããšãç¹åŸŽãšããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ133bã®è£œé
æ³ã ïŒ èŠªæ°Žæ§ææ©æº¶åªãã¢ã«ã³ãŒã«ã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ
133bã®è£œé æ³ã ïŒ èŠªæ°Žæ§ææ©æº¶åªããã®æ¿åºŠã30ã70ïŒ ã«ãªã
ããã«å¹é€æ¶²åã¯äžæž 液ã«å ããããšãç¹åŸŽãšã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ
133bã®è£œé æ³ã ïŒ ã€ãªã³äº€æäœã匱塩åºæ§ã€ãªã³äº€æäœåã¯å
å篩æ§ã䜵æãããã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é åã¯ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ133bã®è£œé
æ³ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â133bçç£èãå¹é€ãããã®å¹é€æ¶²ããåŸãã
ã次ã®æ§ç¶ã (ã€) çœç°è²ãæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°ŽåçããšãŒã«ãªã
ãçµç¯åçãã¶ã«ã³ãŒã180ç现èã®å¢æ®ãé»
æ¢ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ããã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»
ãã³ããã³ãŒã³ãã¯ãããã«ã ãé ¢é žãšãã«ã
ãžãšãã«ãšãŒãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ïŒ2960ã2930ïŒ1670ã1640ïŒ1550ïŒ
1440ã1380ïŒ1240ïŒ1140ã1000åã³820cm-1ã®
è¿åã«åžå垯ãæããã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€ç·åžåã¹ãã¯ãã«ã¯ãåžå
æ«ç«¯ã«åŒ·ãåžåããããå270ã280nmã®è¿å
ã«ã·ãšã«ããŒã瀺ãã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®ç»
é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ21mmÏÃ
400mmã溶åºæ¶²ïŒPH7.0ã®0.1ã¢ã«ãªã³é žç·©è¡æ¶²ïŒ
ã§åç»ãããšã260nmã®çŽ«å€ç·åžå 床枬å®ã«æŒ
ããŠã¯ãã€ãã»ããªãŠã ééä»è¿ãã170mlä»
è¿ã«ãããŠåžå垯ãæããããšããŒã«ç¡«é žæ³ã«
æŒãã490nmã®åžå 床枬å®ã«æŒããŠã¯ãã€ãã»
ããªãŠã ééä»è¿ãã150mlä»è¿ã«åžå垯ãæ
ããã (ã) TSKâGEL  3000SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿ
ã®åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ã
ãé«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPH7.0ã®
0.1ã¢ã«ãªã³é žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒ
ã¯ã220nmã®çŽ«å€ç·åžå 床枬å®ã«æŒããŠã¯ã溶
åªå 端éšåã49ã50åä»è¿ã«ããããŒã¯ãæ
ãã260nmã§ã¯æº¶åªå 端éšåã38ã39åã52å
ä»è¿ã«ãããŠããŒã¯ãæããã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«ç¡«é žåå¿ãã¢
ã³ã¹ãã³ç¡«é žåå¿ãã€ã³ããŒã«å¡©é žåå¿ãããŠ
ãªã€ãŒã»ããªãªã³åå¿ã¯éœæ§ããã³ãããªã³å
å¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ31.1ïŒ ã38.5ïŒ ïŒïŒšïŒ3.9ïŒ ã5.2ïŒ ïŒ
ïŒ3.4ïŒ ã4.7ïŒ ïŒã«ïŒ ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯çŽ
19.0ïŒ ã24.5ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ã
ãŠãªã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯
çŽ12.9ïŒ ã22.9ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§
ããã ãæããå¶çæ§ç©è³ªTFâ133bãå«æããããšã
ç¹åŸŽãšããå¶çå€ã
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10812180A JPS5732294A (en) | 1980-08-06 | 1980-08-06 | Carcinostatic substance tf-133b, its preparation, and carcinostatic agent containing the same |
DE19803031152 DE3031152A1 (de) | 1979-08-24 | 1980-08-18 | Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben |
GB8027026A GB2059969B (en) | 1979-08-24 | 1980-08-19 | Fusobacterium culture extracts |
CA000358667A CA1174618A (en) | 1979-08-24 | 1980-08-20 | Substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same |
BE0/201815A BE884864A (fr) | 1979-08-24 | 1980-08-21 | Nouvelles substances produites par des bacteries du genre fusobacterium, leur procede de preparation et leur application en therapeutique |
AU61646/80A AU529076B2 (en) | 1979-08-24 | 1980-08-21 | Carcinostatic agents |
FI802641A FI68080C (fi) | 1979-08-24 | 1980-08-21 | Foerfarande foer framstaellning av karcinostatiska och immunostimulerande substansen |
AT0426480A AT375674B (de) | 1979-08-24 | 1980-08-21 | Verfahren zur herstellung neuer carcinostatischer substanzen |
CH6297/80A CH648042A5 (de) | 1979-08-24 | 1980-08-21 | Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben. |
US06/180,040 US4744985A (en) | 1979-08-24 | 1980-08-21 | Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same |
FR8018396A FR2463619A1 (fr) | 1979-08-24 | 1980-08-22 | Nouvelles substances produites par des bacteries du genre fusobacterium, leur procede de preparation et leur application en therapeutique |
NL8004759A NL8004759A (nl) | 1979-08-24 | 1980-08-22 | Nieuwe stoffen met carcinostatische en immuno- stimulerende werking, werkwijze voor de bereiding daarvan en carcinostatische preparaten die deze stoffen bevatten. |
NZ194744A NZ194744A (en) | 1979-08-24 | 1980-08-22 | Preparation of carcinostatic and immunostimulating tf-substances from fusobacterium |
PT71730A PT71730A (en) | 1979-08-24 | 1980-08-22 | Process for preparing novel substances having carcinostatic immunostimulating activity and a carcinostatic agent containing the same |
IT49541/80A IT1181595B (it) | 1979-08-24 | 1980-08-22 | Sostanze carcinostatiche ed immuno stimolanti procedimento per prepararle ed agente carcinostatico che le contiene |
DK361680A DK151639C (da) | 1979-08-24 | 1980-08-22 | Fremgangsmaade til fremstilling af tf-100 eller fraktioner heraf med carcinostatisk og immunostimulerende aktivitet |
SE8005921A SE446406B (sv) | 1979-08-24 | 1980-08-22 | Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha |
NO802499A NO155697C (no) | 1979-08-24 | 1980-08-22 | Fremgangsmaate for fremstilling av fysiologisk aktive forbindelser ved fermentering. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10812180A JPS5732294A (en) | 1980-08-06 | 1980-08-06 | Carcinostatic substance tf-133b, its preparation, and carcinostatic agent containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5732294A JPS5732294A (en) | 1982-02-20 |
JPS648637B2 true JPS648637B2 (ja) | 1989-02-14 |
Family
ID=14476449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10812180A Granted JPS5732294A (en) | 1979-08-24 | 1980-08-06 | Carcinostatic substance tf-133b, its preparation, and carcinostatic agent containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5732294A (ja) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55108122A (en) * | 1979-02-13 | 1980-08-19 | Tokyo Shibaura Electric Co | Motorrdriven spring operating device for circuit breaker |
-
1980
- 1980-08-06 JP JP10812180A patent/JPS5732294A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5732294A (en) | 1982-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH021154B2 (ja) | ||
CA1282779C (en) | Polysaccharide ron substance, production of the same and use of the same | |
US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
CA2042536A1 (en) | Method for preparing an antitumor dextran | |
US4209507A (en) | Novel anti-tumor substance and preparation thereof | |
US4744985A (en) | Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same | |
JPS6261036B2 (ja) | ||
JPS648637B2 (ja) | ||
JPS627916B2 (ja) | ||
JPS627918B2 (ja) | ||
US4547462A (en) | Process for preparing substance having carcinostatic and immunostimulating activity | |
KR890002256B1 (ko) | íì ë¬Œì§ tf-2 ì ì¡° ë°©ë² | |
NO155697B (no) | Fremgangsmaate for fremstilling av fysiologisk aktive forbindelser ved fermentering. | |
US4591558A (en) | Novel substances having antitumor and immunostimulating activity, process for preparing the same and antitumor agent containing the same | |
JPH0242478B2 (ja) | ||
JPS627919B2 (ja) | ||
JPH021156B2 (ja) | ||
JPS627917B2 (ja) | ||
JPH021153B2 (ja) | ||
JPH021151B2 (ja) | ||
JPH021152B2 (ja) | ||
JPS6353200B2 (ja) | ||
JPH039120B2 (ja) | ||
JPS6353198B2 (ja) | ||
JPH021157B2 (ja) |